
The Age at Onset of Attention Deficit Hyperactivity Disorder
2010; American Psychiatric Association; Volume: 167; Issue: 1 Linguagem: Inglês
10.1176/appi.ajp.2009.09060796
ISSN1535-7228
AutoresChristian Kieling, Renata R. Kieling, Luís Augusto Rohde, Paul J. Frick, Terrie E. Moffitt, Joel T. Nigg, Rosemary Tannock, F. Xavier Castellanos,
Tópico(s)Bipolar Disorder and Treatment
ResumoBack to table of contents Previous article Next article CommentaryFull AccessThe Age at Onset of Attention Deficit Hyperactivity DisorderChristian Kieling, M.D., Renata R. Kieling, M.D., Luis Augusto Rohde, M.D., Ph.D., Paul J. Frick, Ph.D., Terrie Moffitt, Ph.D., Joel T. Nigg, Ph.D., Rosemary Tannock, Ph.D., and Francisco Xavier Castellanos, M.D.Christian KielingSearch for more papers by this author, M.D., Renata R. KielingSearch for more papers by this author, M.D., Luis Augusto RohdeSearch for more papers by this author, M.D., Ph.D., Paul J. FrickSearch for more papers by this author, Ph.D., Terrie MoffittSearch for more papers by this author, Ph.D., Joel T. NiggSearch for more papers by this author, Ph.D., Rosemary TannockSearch for more papers by this author, Ph.D., and Francisco Xavier CastellanosSearch for more papers by this author, M.D.Published Online:1 Jan 2010https://doi.org/10.1176/appi.ajp.2009.09060796AboutSectionsView articleSupplemental MaterialPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleClassification systems inevitably reflect the state of science at the time they are formalized (1). In psychiatry, DSM-III revolutionized the field of mental health diagnosis in 1980 by eschewing theoretical explanations in favor of diagnostic reliability. Among the major consequences of this initiative was the flourishing of evidence-based research, leading to an exponential growth of psychiatric literature. Since then, some diagnostic criteria have been put to the test and retained, removed, or reconceptualized. A maximum age at onset as a diagnostic criterion for attention deficit hyperactivity disorder (ADHD) was introduced in DSM-III on the basis of clinical experience. In DSM-IV-TR, this B criterion specifies that "some hyperactive-impulsive or inattentive symptoms that caused impairment were present before age 7 years." Over the intervening years, a number of studies have addressed the utility of criterion B, generally questioning its contribution to the validity of the diagnosis of ADHD (2).We performed a systematic review of the literature focusing on studies on the age at onset of ADHD. A search conducted in both MEDLINE and PsycINFO databases retrieved 2,097 abstracts; 31 studies reporting original data on the onset of ADHD were selected. The findings are summarized here; complete results are presented in the supplementary online material.An analysis of the DSM-IV field trials revealed differences in ages at onset according to ADHD subtype, with the inattentive group exhibiting a later onset (3). The authors of this report also questioned the criterion's diagnostic utility, as its adoption increased false negatives in comparison with clinical validation diagnosis (clinicians validated 75% of cases meeting symptom criteria but lacking the onset criterion). Data from an adult population survey showed that only 50% of individuals with clinical features of ADHD retrospectively recalled an onset before age 7; by contrast, 95% recalled an onset before age 12 and 99% before age 16 (4). A series of studies examining later-onset ADHD cases found that individuals who did not meet the onset criterion resembled those with the full diagnosis in terms of neuropsychological profile, comorbidity, substance use, personality traits, and impairment (5–8). Response to treatment with stimulants has also been shown to be similar among children, adolescents, and adults whether or not they met criterion B (9, 10). Cohort studies, which are unbiased by memory recall, have confirmed the similarities between early- and late-onset ADHD groups in terms of psychopathology and impairment (11–13). For example, in a representative sample of the British population prospectively assessed for ADHD, those with symptoms before age 7 years and those with a new onset of symptoms between ages 7 and 12 years did not differ significantly on clinical, cognitive, and impairment measures or in environmental stressors or perinatal risk factors (G. Polanczyk et al., personal communication, 2009). Prospective data also demonstrate the poor stability of the recall of age at onset, with nearly one-half of the children assessed and diagnosed with ADHD not meeting the onset criterion in later life when reassessed retrospectively (12). In contrast, no studies provided significant findings differentiating children with onset before and after age 7 years.Differences in study design hamper a formal meta-analysis of reports focusing on the age at onset of ADHD. In addition, some studies assessed the onset of ADHD symptoms, rather than the onset of impairment, as required by DSM-IV—the latter is more likely to depend on environmental demands, such as school. In keeping with the conceptual decision to differentiate assessments of symptoms and impairment (1), the age at onset of symptoms should be prioritized for diagnostic purposes.In sum, despite a lack of empirical support, the age 7 onset criterion was retained across three DSM editions. Although historically defined as a disorder of childhood, ADHD is increasingly recognized as a valid diagnosis in the adult population, for whom the age at onset criterion is even more problematic because of increased problems with retrospective recall (14). As prospective and retrospective data indicate that only one-half of adults who are assessed for ADHD symptoms report their presence by age 7, an extension of the age at onset criterion is both prudent and necessary. In our review of the literature we found studies with various designs converging on the transition from childhood to adolescence as an optimal cutoff point. Application of such an evidence-based approach to DSM-V provides support for a preliminary recommendation to reformulate the onset criterion by requiring the presence of symptoms by age 12. Such a revision would minimize false negatives, which are particularly likely when cases are assessed later in life, while reaffirming ADHD as a disorder of childhood onset.Address correspondence to Dr. Rohde, Hospital de Clínicas de Porto Alegre, Room 2201A, Ramiro Barcelos 2350, Porto Alegre, Brazil 90035-003; [email protected]com.br (e-mail). Accepted for publication July 2009.Dr. C. Kieling took part in a Novartis-sponsored meeting on ADHD in 2008. Dr. Rohde was on the speakers bureau and/or acted as consultant for Eli Lilly, Janssen-Cilag, and Novartis in the last 3 years; currently he is on the advisory board and/or speakers bureau for Eli Lilly and Novartis (less than $10,000 per year and reflecting less than 5% of his gross income per year); and the ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support in the last 3 years from Abbott, Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, Novartis, and Shire. Dr. Tannock's current and past 3-year involvement with industry consists of serving as a consultant for Eli Lilly, McNeil, Pfizer, and Shire, for which she has received honoraria (less than $10,000 per year, all of which is donated to The Hospital for Sick Children's Foundation to support ADHD research). Drs. R. Kieling, Frick, Moffitt, Nigg, and Castellanos report no financial relationships with commercial interests.References1 Regier DA , Narrow WE , Kuhl EA , Kupfer DJ : The conceptual development of DSM-V (commentary). Am J Psychiatry 2009; 166:645–650 Link, Google Scholar2 Barkley RA , Biederman J : Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:1204–1210 Crossref, Medline, Google Scholar3 Applegate B , Lahey BB , Hart EL , Biederman J , Hynd GW , Barkley RA , Ollendick T , Frick PJ , Greenhill L , McBurnett K , Newcorn JH , Kerdyk L , Garfinkel B , Waldman I , Shaffer D : Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997; 36:1211–1221 Crossref, Medline, Google Scholar4 Kessler R , Berglund P , Demler O , Jin R , Merikangas K , Walters E : Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593–602 Crossref, Medline, Google Scholar5 Faraone S , Biederman J , Doyle A , Murray K , Petty C , Adamson JJ , Seidman L : Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2006; 60:1081–1087 Crossref, Medline, Google Scholar6 Faraone SV , Biederman J , Spencer T , Mick E , Murray K , Petty C , Adamson JJ , Monuteaux MC : Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006; 163:1720–1729 Link, Google Scholar7 Faraone SV , Kunwar A , Adamson J , Biederman J : Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med 2009; 39:685–693 Crossref, Medline, Google Scholar8 Faraone S , Wilens T , Petty C , Antshel K , Spencer T , Biederman J : Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict 2007; 16(suppl 1):24–32 Crossref, Medline, Google Scholar9 Biederman J , Mick E , Spencer T , Surman C , Hammerness P , Doyle R , Dougherty M , Aleardi M , Schweitzer K : An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr 2006; 11:390–396 Crossref, Medline, Google Scholar10 Reinhardt M , Benetti L , Victor M , Grevet E , Belmonte-de-Abreu P , Faraone SV , Rohde LA : Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder? J Clin Psychiatry 2007; 68:1109–1116 Crossref, Medline, Google Scholar11 Barkley R , Fischer M , Edelbrock C , Smallish L : The adolescent outcome of hyperactive children diagnosed by research criteria, I: an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990; 29:546–557 Crossref, Medline, Google Scholar12 Barkley RA , Murphy KR , Fischer M : ADHD in Adults: What the Science Says. New York, Guilford, 2008 Google Scholar13 Todd R , Huang H , Henderson C : Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11. J Child Psychol Psychiatry 2008; 49:942–949 Crossref, Medline, Google Scholar14 McGough JJ , Barkley RA : Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004; 161:1948–1956 Link, Google Scholar FiguresReferencesCited byDetailsCited byAdolescent ADHD and electrophysiological reward responsiveness: A machine learning approach to evaluate classification accuracy and prognosisPsychiatry Research, Vol. 323Combinations of Physical Activity, Sedentary Behavior, and Sleep Duration and Their Associations With Physical, Psychological, and Educational Outcomes in Children and Adolescents: A Systematic Review14 December 2022 | American Journal of Epidemiology, Vol. 192, No. 4Annual Research Review: Perspectives on progress in ADHD science – from characterization to cause11 October 2022 | Journal of Child Psychology and Psychiatry, Vol. 64, No. 4The domain-variant indirect association between electrophysiological response to reward and ADHD presentations is moderated by dopaminergic polymorphismsComprehensive Psychiatry, Vol. 23Pharmacotherapy May Attenuate the Risk of Child Abuse in Attention-Deficit/Hyperactivity Disorder from the Real-World EvidenceJournal of Child and Adolescent Psychopharmacology, Vol. 33, No. 2The course of attention-deficit/hyperactivity disorder through midlife9 December 2022 | European Archives of Psychiatry and Clinical Neuroscience, Vol. 4Centrality and interhemispheric coordination are related to different clinical/behavioral factors in attention deficit/hyperactivity disorder: a resting-state fMRI study21 July 2022 | Brain Imaging and Behavior, Vol. 16, No. 6Examination of developmental pathways from preschool temperament to early adolescent ADHD symptoms through initial responsiveness to reward16 March 2021 | Development and Psychopathology, Vol. 34, No. 3Sex differences in conduct and emotional outcomes for young people with hyperactive/inattentive traits and social communication difficulties between 9 and 16 years of age: a growth curve analysis29 July 2022 | Psychological Medicine, Vol. 33Inconsistent flanker congruency effects across stimulus types and age groups: A cautionary tale29 June 2022 | Behavior Research Methods, Vol. 48The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial14 March 2021 | European Journal of Nutrition, Vol. 60, No. 7Cerebellar-Subcortical-Cortical Systems as Modulators of Cognitive Functions29 January 2021 | Neuropsychology Review, Vol. 31, No. 3The Accuracy of Retrospective Recall of Childhood ADHD: Results from a Longitudinal Study7 December 2020 | Journal of Psychopathology and Behavioral Assessment, Vol. 43, No. 2Integrative analysis of genome-wide association studies identifies novel loci associated with neuropsychiatric disorders21 January 2021 | Translational Psychiatry, Vol. 11, No. 1Understanding the Link Between Allergy and Neurodevelopmental Disorders: A Current Review of Factors and Mechanisms15 February 2021 | Frontiers in Neurology, Vol. 11Shared alterations in resting-state brain connectivity in adults with attention-deficit/hyperactivity disorder and their unaffected first-degree relatives26 November 2019 | Psychological Medicine, Vol. 51, No. 2Behaviors of ADHD and Peer Relationship Difficulties in Chinese and American Youths: Role of Co-Occurring Behaviors of Depression and Anxiety16 July 2020 | The Journal of Genetic Psychology, Vol. 181, No. 5Early life predictors of attention deficit/hyperactivity disorder symptomatology profiles from early through middle childhood23 August 2019 | Development and Psychopathology, Vol. 32, No. 3Neuropsychological Disorders and their NanocarriersCurrent Pharmaceutical Design, Vol. 26, No. 19Revisiting ADHD age-of-onset in adults: to what extent should we rely on the recall of childhood symptoms?10 April 2019 | Psychological Medicine, Vol. 50, No. 5Opposite Control of Excitatory and Inhibitory Synapse Formation by Slitrk2 and Slitrk5 on Dopamine Neurons Modulates Hyperactivity BehaviorCell Reports, Vol. 30, No. 7The role of ADHD symptoms in the relationship between academic achievement and psychopathological symptomsResearch in Developmental Disabilities, Vol. 97Assessment of Attention-Deficit/Hyperactivity and Disruptive Behavior Disorders12 June 2020The Wellbeing of People with Neurodiverse Conditions22 January 2021Clinical and Neuropsychological Characteristics of ADHD According to DSM-5 Age-of-Onset Criterion in Korean Children and Adolescents28 December 2016 | Journal of Attention Disorders, Vol. 24, No. 1Comparison of Neuropsychological Functioning Between Adults With Early- and Late-Onset DSM-5 ADHD12 September 2017 | Journal of Attention Disorders, Vol. 24, No. 1A review of changes to the attention deficit/hyperactivity disorder age of onset criterion using the checklist for modifying disease definitions12 November 2019 | BMC Psychiatry, Vol. 19, No. 1Determinants of inter-practice variation in ADHD diagnosis and stimulant prescribing: cross-sectional database study of a national surveillance network14 February 2019 | BMJ Evidence-Based Medicine, Vol. 24, No. 4Temperament correlates in adult ADHD: A systematic review★★Journal of Affective Disorders, Vol. 252Brain Imaging and Behavior, Vol. 13, No. 3Updated European Consensus Statement on diagnosis and treatment of adult ADHD16 November 2018 | European Psychiatry, Vol. 56, No. 1Psychological Medicine, Vol. 49, No. 07Journal of Child Psychology and Psychiatry, Vol. 60, No. 3Journal of Attention Disorders, Vol. 23, No. 9Journal of Attention Disorders, Vol. 23, No. 11Journal of Attention Disorders, Vol. 23, No. 14Asian Journal of Psychiatry, Vol. 38Child Neuropsychology, Vol. 24, No. 8A Brief History of the Diagnostic Classification of Childhood Externalizing Disorders25 August 2017The development of offspring from mothers with systemic lupus erythematosus. A systematic reviewAutoimmunity Reviews, Vol. 16, No. 7Psychological Medicine, Vol. 47, No. 4Journal of Child and Adolescent Psychopharmacology, Vol. 27, No. 1Acta Psychiatrica Scandinavica, Vol. 136, No. 6Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder23 August 2017 | Journal of Central Nervous System Disease, Vol. 9Child and Adolescent Psychopharmacology News, Vol. 22, No. 5Attention-Deficit/Hyperactivity Disorder3 March 2017 | Deutsches Ärzteblatt internationalRetrospective assessment of childhood ADHD symptoms for diagnosis in adults: validity of a short 8-item version of the Wender-Utah Rating Scale10 August 2016 | ADHD Attention Deficit and Hyperactivity Disorders, Vol. 8, No. 4Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)25 November 2015 | Cochrane Database of Systematic Reviews, Vol. 2016, No. 11Adult ADHD Among NSW Prisoners28 July 2016 | Journal of Attention Disorders, Vol. 20, No. 11Does collateral retrospective information about childhood attention-deficit/hyperactivity disorder symptoms assist in the diagnosis of attention-deficit/hyperactivity disorder in adults? Findings from a large clinical sample12 October 2015 | Australian & New Zealand Journal of Psychiatry, Vol. 50, No. 6Psychiatric comorbidities of adults with early- and late-onset attention-deficit/hyperactivity disorder12 October 2015 | Australian & New Zealand Journal of Psychiatry, Vol. 50, No. 6Changing relationships between smoking and psychiatric disorders across twentieth century birth cohorts: clinical and research implications26 January 2016 | Molecular Psychiatry, Vol. 21, No. 4Attention Deficit Hyperactivity Disorder and DSM 5: What’s New?30 November 2016European Child & Adolescent Psychiatry, Vol. 25, No. 10Research in Autism Spectrum Disorders, Vol. 31Psychological Medicine, Vol. 46, No. 12Journal of Child and Adolescent Psychopharmacology, Vol. 26, No. 6International Journal of Psychiatry in Clinical Practice, Vol. 20, No. 2Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort StudyTerrie E. Moffitt, Ph.D., Renate Houts, Ph.D., Philip Asherson, M.D., Daniel W. Belsky, Ph.D., David L. Corcoran, Ph.D., Maggie Hammerle, B.A., HonaLee Harrington, B.A., Sean Hogan, M.S.W., Madeline H. Meier, Ph.D., Guilherme V. Polanczyk, M.D., Richie Poulton, Ph.D., Sandhya Ramrakha, Ph.D., Karen Sugden, Ph.D., Benjamin Williams, B.A., Luis Augusto Rohde, M.D., Avshalom Caspi, Ph.D.22 May 2015 | American Journal of Psychiatry, Vol. 172, No. 10Aetiological overlap between anxiety and attention deficit hyperactivity symptom dimensions in adolescence8 September 2014 | Journal of Child Psychology and Psychiatry, Vol. 56, No. 4ADHD History of the Concept: the Case of the Continuous Performance Test22 January 2015 | Current Developmental Disorders Reports, Vol. 2, No. 1Risky Sexual Behavior Among College Students With ADHD9 October 2012 | Journal of Attention Disorders, Vol. 19, No. 3Schizophrenia Research, Vol. 165, No. 2-3Psychological Medicine, Vol. 45, No. 10First Treatment Contact for ADHD: Predictors of and Gender Differences in Treatment SeekingElias Dakwar, M.D. Frances R. Levin, M.D. Mark Olfson, M.D., M.P.H. Shuai Wang, Ph.D. Bradley Kerridge Carlos Blanco, M.D., Ph.D.1 December 2014 | Psychiatric Services, Vol. 65, No. 12DSM-5 – Aufmerksamkeitsdefizit-/HyperaktivitätsstörungenZeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, Vol. 42, No. 4Severity But Not Comorbidities Predicts Response to Methylphenidate in Adults With Attention-Deficit/Hyperactivity DisorderJournal of Clinical Psychopharmacology, Vol. 34, No. 2Pearls, perils, and pitfalls in the assessment and treatment of attention-deficit/hyperactivity disorder in adolescentsCurrent Opinion in Pediatrics, Vol. 26, No. 1Social Psychiatry and Psychiatric Epidemiology, Vol. 49, No. 6Journal of Autism and Developmental Disorders, Vol. 44, No. 1Biological Psychiatry, Vol. 76, No. 8Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 53, No. 7Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 53, No. 7International Journal of Mental Health, Vol. 43, No. 4Conceptual Structure of the Symptoms of Adult ADHD According to the DSM-IV and Retrospective Wender-Utah Criteria18 November 2011 | Journal of Attention Disorders, Vol. 17, No. 2European Child & Adolescent Psychiatry, Vol. 22, No. S1The American Journal on Addictions, Vol. 22, No. 1Rethinking ADHD and LD in DSM-5 : Proposed Changes in Diagnostic Criteria9 November 2012 | Journal of Learning Disabilities, Vol. 46, No. 1PLoS ONE, Vol. 8, No. 5PLoS ONE, Vol. 8, No. 12Revista Brasileira de Psiquiatria, Vol. 35, No. suppl 1DSM-5: what is new and what is next?Trends in Psychiatry and Psychotherapy, Vol. 35, No. 3Symptom Dimensions of Attention Deficit Hyperactivity Disorder and Nicotine Withdrawal Symptoms17 December 2012 | Journal of Addictive Diseases, Vol. 31, No. 4The burdened life of adults with ADHD: Impairment beyond comorbidity15 April 2020 | European Psychiatry, Vol. 27, No. 5Developmental differences in structure of attention-deficit/hyperactivity disorder (ADHD) between childhood and adulthood8 June 2012 | International Journal of Behavioral Development, Vol. 36, No. 4Current Issues in the Diagnosis of Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct DisorderAnnual Review of Clinical Psychology, Vol. 8, No. 1Journal of Abnormal Child Psychology, Vol. 40, No. 8ADHD Attention Deficit and Hyperactivity Disorders, Vol. 4, No. 2Neurotherapeutics, Vol. 9, No. 3Journal of Psychiatric Research, Vol. 46, No. 10Psychological Medicine, Vol. 42, No. 4CNS Spectrums, Vol. 17, No. 2Journal of Child and Adolescent Psychopharmacology, Vol. 22, No. 4Arquivos de Neuro-Psiquiatria, Vol. 70, No. 3Personality Disorders in Later Life: Questions About the Measurement, Course, and Impact of DisordersAnnual Review of Clinical Psychology, Vol. 7, No. 1European Child & Adolescent Psychiatry, Vol. 20, No. 2Journal of Psychiatric Research, Vol. 45, No. 6Journal of Clinical Child & Adolescent Psychology, Vol. 40, No. 4Journal of Child Psychology and Psychiatry, Vol. 52, No. 6Neuropsychiatry, Vol. 1, No. 6The Four Causes of ADHD: A Framework29 September 2011De doos van Pandora: openmaken of dicht laten?3 March 2012 | Tijdschrift voor Psychotherapie, Vol. 36, No. 6Effects of childhood development on late-life mental disordersCurrent Opinion in Psychiatry, Vol. 23, No. 6Increasing the Age at Onset for ADHD?Allen Frances, M.D.1 June 2010 | American Journal of Psychiatry, Vol. 167, No. 6Drs. Christian Kieling, Renata Kieling, and Rohde ReplyChristian Kieling, M.D., Renata R. Kieling, M.D., and Luis Augusto Rohde, M.D., Ph.D.1 June 2010 | American Journal of Psychiatry, Vol. 167, No. 6Schizophrenia and Childhood AdversityJohn Read, Ph.D., and Richard Bentall, Ph.D.1 June 2010 | American Journal of Psychiatry, Vol. 167, No. 6Dr. Gilmore RepliesJohn H. Gilmore, M.D.1 June 2010 | American Journal of Psychiatry, Vol. 167, No. 6Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 49, No. 3Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 49, No. 3BMC Psychiatry, Vol. 10, No. 1ADHD in Children and Adults: Diagnosis and Prognosis16 April 2011 Volume 167Issue 1 January 2010Pages 14-16 Metrics PDF download History Accepted 1 July 2009 Published online 1 January 2010 Published in print 1 January 2010
Referência(s)